LMy Longevity Picks
← Blog
Side Effects & Safety4 min read

Methylene Blue Side Effects and Interactions

By Alexandru Vieru · Updated · Independently researched & fact-checked

Methylene Blue Side Effects and Interactions

Summarize this page with

Short answer: the most serious methylene blue risk is not a mild side effect. It is a drug interaction. Taken with common antidepressants (SSRIs, SNRIs, MAOIs) or with opioids, methylene blue can cause serotonin syndrome, which the FDA-approved label calls potentially fatal. The other side effects on the label include headache, nausea, diarrhea, blue-green urine, confusion and dizziness, and severe hemolysis in people with G6PD deficiency.

Every warning below is quoted from the prescribing information for PROVAYBLUE, the FDA-approved methylene blue product, which we read on DailyMed on 1 October 2026. That label describes an intravenous hospital drug. Online "longevity" and "nootropic" use is a different, off-label use, often at different doses and by a different route, so read the label as the documented baseline of known risks, not as a description of what a low oral dose will do to you.

The serotonin syndrome warning comes first

If you take an antidepressant, read this section before anything else.

The PROVAYBLUE label carries a boxed warning, the FDA's most prominent type, titled "Serotonin Syndrome with Concomitant Use of Serotonergic Drugs and Opioids". In its own words: "PROVAYBLUE may cause serious or fatal serotonergic syndrome when used in combination with serotonergic drugs and opioids. Avoid concomitant use of PROVAYBLUE with selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs) and opioids."

The warnings section of the PROVAYBLUE label adds that "The development of serotonin syndrome has been reported with the use of methylene blue class products. Most reports have been associated with concomitant use of serotonergic drugs (e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs). Opioids and dextromethorphan may increase the risk of developing serotonin syndrome."

What that means in practice:

What the FDA-approved product is for

The approved use is narrow. The PROVAYBLUE label states: "PROVAYBLUE is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia." It is given in hospital, by vein; the PROVAYBLUE dosing section reads "Administer 1 mg/kg intravenously over 5-30 minutes."

No FDA label covers methylene blue for energy, cognition or aging. Clinics that prescribe it for longevity are prescribing off-label, usually as a compounded product.

Other side effects on the label

The PROVAYBLUE label lists its most frequent reactions in hospital use: "The most commonly reported adverse reactions (>2%) included headache, hypokalemia, diarrhea, hypomagnesemia, myoclonus, nausea, and seizure-like phenomena."

Further warnings in the PROVAYBLUE label:

Questions to ask a clinician before starting

Who prescribes methylene blue online, at prices we verified

Two of the 28 clinics we track list methylene blue on their own sites: RxSpan MD and Get Heally.

A clinic listing methylene blue tells you nothing about whether it is right for you. If you take an antidepressant or an opioid, the label's boxed warning applies before any price does.

For another prescription compound longevity clinics offer, see sermorelin side effects. Every clinic we track, with its score and published prices, is in our ranked list.

Medical disclaimer: this article summarizes the FDA-approved label and is not medical advice. Do not start, stop or combine medications without a licensed clinician who knows your full medication list.

Written to inform a purchase decision, not to replace a conversation with your own prescriber. A subset of the links above are paid referrals, see the badge on each one, and the score attached to any clinic named here doesn't know or care whether it's one of them.

Alexandru Vieru · Founder & Editor

Alexandru Vieru founded and edits My Longevity Picks, and personally re-checks every price, medication list and refund policy the site publishes before it goes live. That's what feeds the site's 4-criteria, 1-to-10 rubric. He holds no medical license, so any clinical fact on this site traces back to something citable (an FDA page, a manufacturer's own label, a peer-reviewed paper), never his own judgment.

Keep reading

Ranked by score

Top-rated clinics

HealthRXfrom $161/mo on a 1-month plan, renewing monthly

Published prices on every product

Paid link · ranks 1 of 31 on our methodology either way
Visit →Read review
MadeMedfrom $169/mo on a 6-month plan billed $1,014

Best for clinical specificity

Ranks 2 of 31 · no commercial relationship
Read the MadeMed review
Ivy RxIvy Rxfrom $175 with no billing period stated

Best named clinical oversight

Ranks 3 of 31 · no commercial relationship
Read the Ivy Rx review

One of these earns us a commission if you sign up. Scores are unaffected; partners are listed first at equal displayed scores. How this works →